Existing and novel biological therapeutics in suicide prevention

American Journal of Preventive Medicine

Volumn 47, Issue 3 SUPPL. 2, 2014, Pages

  Griffiths, Joshua J ^a   Zarate Jr , Carlos A ^b   Rasimas, J J ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; KETAMINE; LITHIUM; NEUROLEPTIC AGENT; BIOLOGICAL MARKER;

ARTICLE; CLINICAL RESEARCH; ELECTROCONVULSIVE THERAPY; ENDOPHENOTYPE; HUMAN; INTERVENTION STUDY; META ANALYSIS; NEUROBIOLOGY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUICIDAL IDEATION; SUICIDE; TRANSCRANIAL MAGNETIC STIMULATION; METABOLISM; PROCEDURES; PSYCHOLOGY; SUICIDE, ATTEMPTED;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIOMARKERS; ELECTROCONVULSIVE THERAPY; HUMANS; SUICIDAL IDEATION; SUICIDE; SUICIDE, ATTEMPTED; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84906305557     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2014.06.012     Document Type: Article

References (56)

1. WHO SUPRE information leaflet 2002 WHO Geneva www.who.int/entity/mental- health/management/en/SUPRE-flyer1.pdf
2. I.R. Rockett, M.D. Regier, and N.D. Kapusta et al. Leading causes of unintentional and intentional injury mortality: U.S., 2000-2009 Am J Public Health 102 11 2012 e84 e92
3. CDC Trends in suicide rates among persons ages 10 years and older, by sex, U.S., 1991-2009 2014 CDC Atlanta GA cdc.gov/violenceprevention/suicide/ statistics/trends01.html
4. J.T. Cavanagh, A.J. Carson, M. Sharpe, and S.M. Lawrie Psychological autopsy studies of suicide: a systematic review Psychol Med 33 3 2003 395 405
5. A. Milner, J. Sveticic, and D. De Leo Suicide in the absence of mental disorder? A review of psychological autopsy studies across countries Int J Soc Psychiatry 59 6 2013 545 554
6. J.J. Mann, C. Waternaux, G.L. Haas, and K.M. Malone Toward a clinical model of suicidal behavior in psychiatric patients Am J Psychiatry 156 2 1999 181 189
7. M.E. O'Neil, K. Peterson, and A. Low et al. Suicide prevention interventions and referral/follow-up services: a systematic review 2012 Department of Veterans Affairs, Health Services Research and Development Service Washington DC VA-ESP Project #05-225. www.hsrd.research.va.gov/publications/ esp/suicide-interventions.pdf
8. O'Connor E, Gaynes B, Burda BU, et al. Screening for suicide risk in primary care: a systematic evidence review for the U.S. Preventive Services Task Force. ncbi.nlm.nih.gov/books/NBK137737/.
9. NICE. Self-harm: the NICE guideline on longer-term management. nccmh.org.uk/guidelines-selfharm-ltm.html.
10. M. Zimmerman, J.I. Mattia, and M.A. Posternak Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 159 3 2002 469 473
11. C.J. Whittington, T. Kendall, P. Fonagy, D. Cottrell, A. Cotgrove, and E. Boddington Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data Lancet 363 9418 2004 1341 1345
12. American Psychiatric Association Diagnostic and statistical manual of mental disorders 5th ed 2013 APA Washington DC
13. C.M. van der Feltz-Cornelis, M. Sarchiapone, and V. Postuvan et al. Best practice elements of multilevel suicide prevention strategies Crisis 32 6 2011 319 333
14. J. Nielsen, M. Dahm, H. Lublin, and D. Taylor Psychiatrists' attitude towards and knowledge of clozapine treatment J Psychopharmacol 24 7 2010 965 971
15. Pharmacy Times. Top 200 drugs of 2011. Plainsboro NJ: Pharmacy Times, 2012. www.pharmacytimes.com/-media/-pdf/Top-200-Drugs-2011-Total-Rx.pdf.
16. H.Y. Meltzer, L. Alphs, and A.I. Green et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT) Arch Gen Psychiatry 60 1 2003 82 91
17. H.Y. Meltzer, R. Anand, and L. Alphs Reducing suicide risk in schizophrenia: focus on the role of clozapine CNS Drugs 14 5 2000 355 365
18. C.E. Marx, L.J. Shampine, and G.E. Duncan et al. Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy? Pharmacol Biochem Behav 84 4 2006 598 608
19. J.C. Leveque, W. Macías, and A. Rajadhyaksha et al. Intracellular modulation of NMDA receptor function by antipsychotic drugs J Neurosci 20 11 2000 4011 4020
20. H.W. Kim, Y. Cheon, H.R. Modi, S.I. Rapoport, and J.S. Rao Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain Psychopharmacology 222 4 2012 663 674
21. R.W. Lam, S.H. Kennedy, and S. Grigoriadis et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy J Affect Disord 117 S1 2009 S26 S43
22. M.F. Grunebaum, S.P. Ellis, N. Duan, A.K. Burke, M.A. Oquendo, and J. John Mann Pilot randomized clinical trial of an SSRI vs bupropion: effects on suicidal behavior, ideation, and mood in major depression Neuropsychopharmacology 37 3 2012 697 706
23. M.A. Oquendo, H.C. Galfalvy, and D. Currier et al. Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior Am J Psychiatry 168 10 2011 1050 1056
24. A. Khan, S.R. Khan, and J. Hobus et al. Differential pattern of response in mood symptoms and suicide risk measures in severely ill depressed patients assigned to citalopram with placebo or citalopram combined with lithium: role of lithium levels J Psychiatr Res 45 11 2011 1489 1496
25. P. Rucci, E. Frank, and P. Scocco et al. Treatment emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial Depress Anxiety 28 4 2011 303 309
26. E. Lauterbach, W. Felber, and B. Muller-Oerlinghausen et al. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial Acta Psychiatr Scand 118 6 2008 469 479
27. H. Reeves, S. Batra, R.S. May, R. Zhang, D.C. Dahl, and X. Li Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study J Clin Psychiatry 69 8 2008 1228
28. E. Lauterbach, B. Ahrens, and W. Felber et al. Suicide prevention by lithium SUPLI - challenges of a multi-center prospective study Arch Suicide Res 9 1 2005 27 34
29. R.J. Verkes, R.C. Van der Mast, M.W. Hengeveld, J.P. Tuyl, A.H. Zwinderman, and G.M. Van Kempen Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression Am J Psychiatry 155 4 1998 543 547
30. D.C. Mathews, E.M. Richards, M.J. Niciu, D.F. Ionescu, J.J. Rasimas, and C.A. Zarate Neurobiological aspects of suicide and suicide attempts in bipolar disorder Transl Neurosci 2013 In press
31. A. Cipriani, H. Pretty, K. Hawton, and J.R. Geddes Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials Am J Psychiatry 162 10 2005 1805 1819
32. A. Cipriani, K. Hawton, S. Stockton, and J.R. Geddes Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis BMJ 346 2013 f3646
33. R.J. Baldessarini, L. Tondo, P. Davis, M. Pompili, F.K. Goodwin, and J. Hennen Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review Bipolar Disorders 8 5 Pt 2 2006 625 639
34. B. Müller-Oerlinghausen, B. Ahrens, and W. Felber The suicide-preventive and mortality reducing effect of lithium Lithium in neuropsychiatry: the comprehensive guide 2006 Informa Healthcare Oxfordshire
35. F. Guzzetta, L. Tondo, F. Centorrino, and R.J. Baldessarini Lithium treatment reduces suicide risk in recurrent major depressive disorder J Clin Psychiatry 68 3 2007 380 383
36. B. Muller-Oerlinghausen Arguments for the specificity of the antisuicidal effect of lithium Eur Arch Psychiatry Clin Neurosci 251 2S 2001 S1172 S1175
37. G. Isacsson, A. Holmgren, U. Ösby, and J. Ahlner Decrease in suicide among the individuals treated with antidepressants: a controlled study of antidepressants in suicide, Sweden 1995-2005 Acta Psychiatrica Scandinavica 120 1 2009 37 44
38. G. Isacsson, U. Bergman, and C.L. Rich Epidemiological data suggest antidepressants reduce suicide risk among depressives J Affect Disorders 41 1 1996 1 8
39. R.H. Weisler, A. Khan, and M.H. Trivedi et al. Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder J Clin Psychiatry 72 4 2011 548 555
40. A. Ward, K. Ishak, I. Proskorovsky, and J. Caro Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study Clin Ther 28 11 2006 1912 1921
41. K.E. Saunders, and K. Hawton The role of psychopharmacology in suicide prevention Epidemiol Psychiatr Soc 18 3 2009 172 178
42. B.I. Yerevanian, R.J. Koek, and J. Mintz Bipolar pharmacotherapy and suicidal behavior: part 3: impact of antipsychotics J Affect Disorders 103 1-3 2007 23 28
43. R. Ferrucci, M. Bortolomasi, and Vergari et al. Transcranial direct current stimulation in severe, drug-resistant major depression J Affect Disord 118 1-3 2009 215 219
44. C.A. Zarate, J.B. Singh, and P.J. Carlson et al. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 8 2006 856 864
45. C.A. Zarate Jr, N.E. Brutsche, and L. Ibrahim et al. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial Biol Psychiatry 71 11 2012 939 946
46. R.M. Berman, A. Cappiello, and A. Anand et al. Antidepressant effects of ketamine in depressed patients Biol Psychiatry 47 4 2000 351 354
47. E.T. Kavalali, and L.M. Monteggia Synaptic mechanisms underlying rapid antidepressant action of ketamine. Am J Psychiatry 169 11 2012 1150 1156
48. J. Burgdorf, X.L. Zhang, and K.L. Nicholson et al. GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects Neuropsychopharmacology 38 5 2013 729 742
49. C.A. Zarate Jr., D. Mathews, and L. Ibrahim et al. A randomized trial of a low-trapping nonselective N-methyl-d-aspartate channel blocker in major depression Biol Psychiatry S0006-3223 12 2012 941 949
50. N. DiazGranados, L.A. Ibrahim, and N.E. Brutsche et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-d-aspartate antagonist in patients with treatment-resistant major depressive disorder J Clin Psychiatry 71 12 2010 1605 1611
51. S. Erhardt, C.K. Lim, and K.R. Linderholm et al. Connecting inflammation with glutamate agonism in suicidality Neuropsychopharmacology 38 5 2013 743 752
52. G.L. Larkin, and A.L. Beautrais A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department Int J Neuropsychopharmacol 14 8 2011 1127 1131
53. T.R. Insel, S.E. Morris, and R.K. Heinssen Standardization, integration, and sharing-leveraging research investments Biol Psychiatry 70 1 2011 5 6
54. S. Richard-Devantoy, M.T. Berlim, and F. Jollant A meta-analysis of neuropsychological markers of vulnerability to suicidal behavior in mood disorders Psychol Med 44 8 2013 1663 1673
55. M.K. Nock, I. Hwang, N.A. Sampson, and R.C. Kessler Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication Mol Psychiatr 15 8 2009 868 876
56. A. Chatzittofis, P. Nordström, C. Hellström, S. Arver, M. Åsberg, and J.CSF Jokinen 5-HIAA, cortisol and DHEAS levels in suicide attempters Eur Neuropsychopharmacol 23 10 2013 1280 1287